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ImmunePlexins are a family of single-pass transmembrane proteins that serve as cell surface receptors for
Semaphorins during the embryonic development of animals. Semaphorin–Plexin signaling is critical for many
cellular aspects of organogenesis, including cell migration, proliferation and survival. Until recently, little was
known about the function of PlexinD1, the sole member of the vertebrate-speciﬁc PlexinD (PlxnD1)
subfamily. Here we review novel ﬁndings about PlxnD1's roles in the development of the cardiovascular,
nervous and immune systems and salivary gland branching morphogenesis and discuss new insights
concerning the molecular mechanisms of PlxnD1 activity.(J. Torres-Vázquez).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Meet the plexins
In 1995 the Xenopus cell surface axonal antigen B2 was cloned and
shown to encode a novel single-pass type I transmembrane protein
with calcium-dependent homophilic cell adhesion properties and
three extracellular cysteine-rich clusters similar to those found in the
oncogenic family of MET/HGF (Mesenchymal–Epithelial Transition
factor/Hepatocyte Growth Factor) tyrosine kinase receptors (Ohta
et al., 1995). The new molecule was renamed Plexin (Plxn) to
highlight its role in organizing the plexiform layers of the neural
retina (Ohta et al., 1992; Satoda et al., 1995).
Soon the ﬁrst mammalian Plxns were discovered and found to
bind to Semaphorins (Semas), a large family of related extracellular
proteins that includes both secreted (class 2 and 3) and membrane-
tethered (classes 1, 4–7 and V) forms (Comeau et al., 1998;
Kameyama et al., 1996a,b; Maestrini et al., 1996). The ﬁrst human
Plxns were identiﬁed in 1996 (Maestrini et al., 1996). The cloning of
human Plxns was completed in 1999 and the current system of Plxnclassiﬁcation which groups these proteins into one of four subfamilies
(A, B, C and D) based on the sequence similarity of their ectodomains
was simultaneously devised (Tamagnone et al., 1999). In 1998 studies
revealed that Drosophila PlxnA, which is expressed in the developing
nervous system, functions as a Sema-responsive axon guidance
receptor, thus uncovering the role of Plxns as Sema receptors
(Winberg et al., 1998).
Today we know that Sema–Plxn signaling is important during
eumetazoan development not only for axonal guidance, but also for
the patterning of many other tissues and organs (see Roth et al., 2009;
Yazdani and Terman, 2006). In this review we focus on PlxnD1
(Tamagnone et al., 1999), the sole member of the vertebrate-speciﬁc
D subfamily of Plxn receptors and a key player in vascular, neuronal
and immune system development implicated in the etiology of
congenital defects and cancer.The developmental biology of PlxnD1
It is in your blood (vessels)
plxnD1 is dynamically expressed in many embryonic tissues. In
particular, plxnD1 transcripts are prominent in endothelial cells of the
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embryos plxnD1 expression is found in most, if not all, of the vascular
endothelium. By E14.5–18.5 plxnD1 continues to be expressed in both
the endothelium and the heart's endocardium. Similarly, early
embryonic plxnD1 expression in the zebraﬁsh is mostly endothelial-
speciﬁc (Cheng et al., 2001; Gitler et al., 2004; Gu et al., 2005; Torres-
Vázquez et al., 2004; van der Zwaag et al., 2002; Zhang et al., 2008).
Sema3–PlxnD1 signaling guides angiogenic pathﬁnding
The reproducible anatomy of the vasculature ensures homeostasis
and survival by enabling the adequate distribution of gases,
metabolites, hormones and immunity factors through the body
(Jain, 2003; Weinstein, 1999). Others and we have shown that the
stereotypical organization of the blood vessels is guided by the same
genetic mechanisms that guide axons (reviewed in Carmeliet and
Tessier-Lavigne, 2005). For example, vertebrate-speciﬁc Semas of the
class 3 (Sema3s) inhibit the migration of neuronal growth cones
expressing both Plxns and Neuropilins (Nrps/Npns) to restrict their
navigation pathways (reviewed in Casazza et al., 2007; Shim and
Ming, 2007). Nrps are cell surface transmembrane proteins that are
expressed in both the nerves and the endothelium that serve as
Sema3 and VEGF (Vascular Endothelial Growth Factor) co-receptors
for Plxns and VEGFR-2 (VEGF Receptor 2/Flk1/Kdr/), respectively
(reviewed in Geretti et al., 2008; Schwarz and Ruhrberg, 2010).
Pioneer in vitro and in vivo experiments revealed that endothelial
cells also respond to Sema3 cues. Given that Nrps act as VEGF co-
receptors during cardiovascular development, the inhibitory effect of
Sema3s on angiogenic sprouting and endothelial cell migration was
attributed to Sema3/VEGF competition for Nrp binding (Bates et al.,
2003; Miao et al., 1999; Shoji et al., 2003). However, an alternative
molecular mechanism for explaining the effects of Sema3s on
cardiovascular development was suggested by the endothelial
expression of plxnD1 in both mouse and zebraﬁsh embryos (Torres-
Vázquez et al., 2004; van der Zwaag et al., 2002). By following upon
this observation we, along with others, were able to demonstrate that
paracrine Sema3 signaling via PlxnD1 guides the anatomical pattern-
ing of speciﬁc subsets of angiogenic vessels (Gitler et al., 2004; Gu
et al., 2005).
For example, in our studies we used time-lapse confocal imaging
to visualize the developing zebraﬁsh vasculature in embryos carrying
endothelial-speciﬁc ﬂuorescent reporters. In wild type animals
angiogenic Segmental Arteries (SeAs) sprout next to the somite
boundaries from both the left and right sides of the Dorsal Aorta (DA)
at approximately 21 hours post-fertilization (hpf). These nascent
vessels extend dynamic ﬁlopodia-like processes as they grow dorsally
acquiring a characteristic chevron shape that reﬂects their trajectory,
which tracks along most of the somite boundary. By 30–32 hpf the
SeAs have extended past the roof of the neural tube. Here they branch
in an antero-posterior manner, interconnecting with their ipsilateral
neighbors to form each of the two Dorsal Longitudinal Anastomotic
Vessels (DLAVs) that run along the trunk dorsally to the neural tube
(Fig. 2C) (Isogai et al., 2003; Torres-Vázquez et al., 2004).
In contrast, plxnD1-deﬁcient embryos, such as out of bounds (obd)
homozygous mutants and wild type animals injected with anti-
plxnD1morpholinos show dramatic defects in SeA development, such
as premature and ectopic sprouting, aberrant pathﬁnding accompa-
nied by the formation of abnormally long ﬁlopodia and improper
branching (Fig. 2D). In contrast, plxnD1 is not required for DLAV
positioning, vascular lumenization or circulatory blood ﬂow (Childs
et al., 2002; Torres-Vázquez et al., 2004).
The class 3 Semas encoded by the zebraﬁsh sema3aa/3a1 (Shoji
et al., 1998) and sema3ab/3a2 (Shoji et al., 2003) genes are expressed
in the developing somites, in overlapping patterns that are largely
complementary to the paths followed by growing SeA sprouts
(Fig. 2E). Zebraﬁsh embryos with reduced Sema3a function display
disorganized SeAs, similar to those found in plxnD1-deﬁcient animals.Conversely, somite-speciﬁc over-expression of Sema3s inhibits SeA
growth in a plxnD1-dependent manner (Torres-Vázquez et al., 2004).
Together, our ﬁndings indicate that paracrine repulsive Sema3–
PlxnD1 signaling from the somites to the developing vasculature
shapes the reproducible anatomy of the SeAs by regulating funda-
mental aspects of their angiogenic development, such as their
sprouting schedule, launching position, pathﬁnding and branching
morphogenesis (Fig. 2F).
Importantly, studies about the role of PlxnD1 (Gitler et al., 2004;
Gu et al., 2005; Zhang et al., 2008) and its canonical murine ligand,
Sema3E (Gitler et al., 2004; Gu et al., 2005) fully support this model.
For example, knockout mouse embryos lacking either PlxnD1
(plxnD1KO) or Sema3E activity show identical Se vessel phenotypes
(Figs. 2A–B), which parallel those of obd mutants. Accordingly,
Sema3E induces the collapse of PlxnD1-expressing COS-7 cells and
vascular repulsion in chick (Gitler et al., 2004; Gu et al., 2005). Finally,
two lines of evidence indicate that Sema3–PlxnD1 signaling is
required in the endothelium for proper Se vessel development. First,
endothelial-speciﬁc inactivation of murine plxnD1 (plxnD1ECKO) using
a ﬂoxed allele induces all of the cardiovascular defects observed in
plxnD1KOmice (Zhang et al., 2008). Second, we found that SeA defects
of obd mutants are rescued when wild type, exogenous plxnD1 cDNA
is provided in an endothelial-speciﬁc manner (Tomasz Zygmunt and
Jesús Torres-Vázquez, unpublished results). However, the cell
autonomy of plxnD1 in the endothelium has not been deﬁned.
Nonetheless, these observations indicate that Sema3–PlxnD1 signal-
ing plays an evolutionarily conserved role in shaping the anatomy of
the Se vessels.Beyond Se vessel development
plxnD1KO mouse embryos also display hypervascularization of the
heart's epicardium (Gitler et al., 2004), ectopic vascular branching in
the hindbrain (Vieira et al., 2007) and reduction of the fourth and
sixth aortic arch arteries. Furthermore, the pups exhibit mispatterned
intercostal vessels and persistent truncus arteriosus (PTA), a congen-
ital form of heart disease caused by defective remodeling of the heart's
outﬂow tract (OT). Speciﬁcally, a lack of conotruncal septation fails to
separate the pulmonary artery and the aorta, leading to perinatal
cyanosis and lethality (Figs. 2G–H).
Notably, migration of cardiac neural crest cells (which also express
plxnD1) is not impaired in plxnD1KO embryos, thus suggesting that the
PTA's etiology is endothelial-speciﬁc. Similar OT abnormalities are
observed in animals lacking Sema3C or with impaired Nrp activity, but
not in sema3e-deﬁcient animals, suggesting that loss of Sema3C–PlxnD1/
Nrp1 signaling is the cause for these abnormalities. Accordingly, Sema3C
binds toNrps inanenhancedmanner in thepresencePlxnD1(Gitler et al.,
2004) (see also Banu et al., 2006; Gu et al., 2003; Toyofuku et al., 2008).
In contrast to mice, zebraﬁsh lack OT septation. This allows the
survival of obd mutants and enables the analysis of phenotypes
related to loss of plxnD1 activity through life (Childs et al., 2002; Gitler
et al., 2004). We have found that in adult obd mutants the
stereotypical organization of the ﬁn vasculature is disrupted (Jesús
Torres-Vázquez, unpublished observations).
Surprisingly, even the morphogenesis of some vascular beds that
do not exhibit a ﬁxed anatomical pattern is also plxnD1-dependent.
For example, obdmutant embryos display retinal (Alvarez et al., 2009,
2007) and subintestinal vessels that are aberrantly branched (Jesús
Torres-Vázquez, unpublished observations) as well as abnormal
remodeling of the caudal vein plexus (Torres-Vázquez et al., 2004).
Importantly, similar defects in retinal vasculature organization are
observed in mice with endothelial-speciﬁc deletion of plxnD1 activity
(Zhang et al., 2008). Overall, these observations indicate that
endothelial PlxnD1 activity plays an evolutionarily conserved role
in shaping many different vascular beds, including vessels with
stereotypical and non-stereotypical anatomies.
Fig. 1. Expression of plxnD1mRNA and PlxnD1 protein in the cardiovascular, immune, nervous and skeletal systems. A–E, Endothelial-speciﬁc expression of plxnD1mRNA (A, purple;
B–C, blue) and PlxnD1 protein (D–E). A, E9.5mouse embryo (left lateral view). The head is up. Anterior dorsal side, left. plxnD1 is detected in the entire vasculature. Segmental vessel,
yellow arrow. B, C, 28 hpf zebraﬁsh embryo. Left lateral views. Anterior, left. Dorsal is up. B, plxnD1 is detected in the entire vasculature. C, Trunk detail. Segmental Arteries (SeAs;
black arrowhead). Dorsal Aorta (DA; red arrowhead). Posterior Cardinal Vein (PCV; yellow arrowhead). Floorplate's hypochord, black asterisk. D, E11.5 murine heart cross-section.
PlxnD1 (brown). E, Murine dorsal root ganglia (DRG; blue, delimited by yellow dotted line). Vessel with PlxnD1 (green) expression, yellow arrow. F, Murine immune system
(parafﬁn section of the thymus). Cortical thymocytes expressing PlxnD1, dark blue. G–J, Expression of plxnD1/PlxnD1 in the murine nervous system. G, P8 cortex section. Only some
cortical commissural neurons (callosal projection neurons; CPN, red) express plxnD1 (green) (rectangle). H, E14.5 murine section of the brain. Forebrain, fb. Trigeminal ganglion, gv.
Choroid plexus, cp. plxnD1, red. I–J, Diagrams of coronal sections of E17.5 murine forebrains showing sites were Sema3E (blue) and PlxnD1 (red) are expressed and locales where
PlxnD1 and Nrp1 are co-expressed (light orange). Rostral, left. Caudal, right. Dorsal is up. I, PlxnD1 is expressed along the corticofugal and striatonigral projections that originate from
the ventrolateral cortex (Ctx) and striatum (St), respectively and which transverse both the internal capsule (ic) and the cerebral peduncle (cp). At the level of the midbrain the
striatonigral projections leave the cp and terminate in the substantia nigra (SN), while corticofugal axons continue into the pons (not shown). Robust Sema3E expression is observed
in the globus pallidus (GP) and thalamic reticular nucleus (TRN). J, PlxnD1 and Nrp1 are co-expressed in the subiculo-mammillary tract, which projects from the subiculum (Sub)
through the ﬁmbria (ﬁm), fornix (f) and postcommissural fornix (pf). Sema3E expression is observed in the hippocampal pyramidal cell layers of the cornus ammonis 1 and 3 (CA1/
3) adjacent to the Sub. The anterior commissure (ac), hippocampal commissure (hipc) and septum (Sp) are indicated. K, E18.5 murine vertebral bodies, lateral cross-section.
Ossiﬁcation center, oc. plxnD1, red.
Credits for reproduced and/or modiﬁed images: A, D and E are from Gitler et al. (2004); B and C are from Torres-Vázquez et al. (2004); F is from Choi et al. (2008); G is from
Molyneaux et al. (2009a); H and K are from Zhang et al. (2008); I–J are from Chauvet et al. (2007).
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PlxnD1 ligand inmice, althoughof lowafﬁnity. Sema4A is expressed in the
heart's ventricle and the Se vessels of E10.5 embryos. Although Sema4A
appears to suppress angiogenesis in a PlxnD1-dependent manner,
Sema4A does not appear to be involved in shaping the vasculature,
since Sema4A-deﬁcientmice display normally patterned vessels. Instead,
Sema4A-deﬁcient adult mice exhibit enhanced wound-induced neo-
angiogenesis (Kumanogoh et al., 2005; Toyofuku et al., 2007).
Finally, endothelial PlxnD1 signaling appears to be required for
proper development of the heart's myocardium and bones. For
example, plxnD1ECKO mouse embryos display atrial defects and
ventricular septal abnormalities. These phenotypes are likely due to
disrupted endocardial–myocardial communication. In addition,
plxnD1KO and plxnD1ECKO mice display defects in the patterning of
the axial skeleton (Figs. 2I–J), such as hemivertebrae and vertebral
fusions, which likely stem from improper bone vascularization (Kanda
et al., 2007; Toyofuku et al., 2007).
Getting nervous
plxnD1 transcription occurs also in the nervous system (Figs. 1G–H).
In the E14.5–18.5mouse embryo plxnD1 is expressed in the CNS at theforebrain, trigeminal and dorsal root ganglia and choroid plexus
(Zhang et al., 2008). At E15.5–E17.5 plxnD1 is expressed in the cortex's
ventrolateral regions (piriform, perirhinal, and insular cortices),
striatum and the pyramidal layer of the subiculum during the
formation of the forebrain's descending axon tracts. In particular, at
E17.5 plxnD1 is expressed in the cortifugal and striatonigral projec-
tions that grow through the mesencephalic cerebral peduncle to
innervate lower brain centers as well as the subiculo-mammillary
tract, the main output structure of the hippocampus (Chauvet et al.,
2007). In addition, postnatal day 1 (P1) mice display plxnD1
expression in the hippocampus (outer molecular layer of the dentate
gyrus and the stratum lacunosum moleculare layers of the cornua
ammonis 1 and 2). In P14 mice plxnD1 is expressed in a subset of
callosal projection neurons (Cheng et al., 2001; Molyneaux et al.,
2009b) and in adults it is expressed in the amygdala (D'Souza et al.,
2008). Finally, plxnD1 is expressed in the neocortex of both mature
mice and Japanese macaques in a laminar distribution that is
complementary to that of its ligand, sema3e (Watakabe et al., 2006).
Wiring the brain
Sema–Plxn signaling is important for both axonal guidance and
pruning (reviewed in Waimey and Cheng, 2006). Accordingly, both
Fig. 2. Sema/PlxnD1 signaling functions to pattern the cardiovascular, skeletal and nervous systems. A–B, E11.5 murine trunks. Lateral views. Dorsal is up. Endothelium, dark brown.
A, Phenotypically wild type sema3E+/− heterozygote. Segmental vessel, white arrow. Note loss of avascular areas. B, sema3E−/− homozygous mutant displaying disorganized
Segmental vessels. Notably, plxnD1−/− homozygous mutants display identical vascular patterning defects (not shown). C, D, 48 hpf zebraﬁsh embryos. Lateral views. Anterior, left.
Dorsal is up. Endothelium, green. Segmental Arteries (SeAs), white arrowheads. Dorsal Aorta (DA), red arrowheads. Posterior Cardinal Vein (PCV), yellow arrowheads. C, Wild type.
D, Animal lacking plxnD1 activity. Note aberrant vascular pattern, resembling that of sema3E−/− homozygous mutant mice (B). E, Model for the evolutionarily conserved role of
Sema–PlxnD1 signaling in shaping the Segmental vasculature. Paracrine Sema signals from the somites (pink) are sensed by PlxnD1 receptors expressed in the endothelium (blue) to
guide the patterning of nascent Se vessels via a repulsive mechanism. F, Without Sema–PlxnD1 signaling Se vessels grow aberrantly. G–H, plxnD1 activity is required for proper
formation of the murine heart's outﬂow tract. Images of P0-stage hearts. G, Wild type heart showing two major vessels, the aorta (Ao) and the pulmonary artery (PA). H, plxnD1
mutant displaying persistent truncus arteriosus (TA; a single great vessel), a form of congenital heart disease. In addition, the coronary artery (white arrow) displays an abnormal
origin. I–J, P0 murine lumbar skeletons (dorsal views) anterior, left. Mineralized bone, red. Cartilage, blue. I, Wild type. J, plxnD1−/−mutant pup showing axial skeletal defects and
malformations such as splitting (green arrow) and fusion (green circle) of the vertebral bodies. K, Connectivity patterns between sensory andmotor neurons in the triceps (Tri, dark
brown) and cutaneous maximus (Cm, light green) reﬂex arcs in the mouse. Muscles, ovals (Tri; light brown, Cm; dark green). Dotted lines surround synapses between sensory
afferents andmotor neurons in these reﬂex arcs. L, Diagram summarizing the role of Sema3E–PlxnD1 repulsive signaling in establishing the ﬁne synaptic speciﬁcity between sensory
afferents (top) and motor neurons (bottom) in the Cm (green) and Tri (brown) arcs. Left half, wild type wiring pattern. Normally, plxnD1 is expressed in both Cm and Tri sensory
neurons and sema3E is expressed only in Cm motor neurons. Therefore only the Tri motor neurons receive direct proprioceptive inputs from Tri sensory neurons (homonymous
connectivity). The right half of the ﬁgure shows the rewiring of homonymous connectivity resulting from perturbing Sema3E–PlxnD1 signaling. Absence of either plxnD1 activity or
sema3E expression induces abnormal homonymous monosynaptic Cm connectivity (left). In contrast, ectopic sema3E expression in the Tri motorneurons (right) prevents the
establishment of monosynaptic connections in the Tri reﬂex arc. Notably, perturbing Sema3E–PlxnD1 signaling does not induce heteronymous sensory–motor connections (Cm to
Tri or vice versa). This indicates that additional factors regulate motor pool speciﬁcity.
Credits for reproduced and/or modiﬁed images: A–B are from Gu et al. (2005); C–F are from Torres-Vázquez et al. (2004); G–H are from Gitler et al. (2004); I–J are from Zhang et al.
(2008); K is adapted from Maro et al. (2009) L is adapted from Pecho-Vrieseling et al. (2009).
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neuronal circuits. For example, in the E17.5 forebrain PlxnD1 is
expressed in the descending cortifugal and striatonigral tracts
(Fig. 1I). Both tracts share a common caudal projecting pathway,
crossing through the internal capsule and the cerebral peduncle to
reach their lower brain center targets (the midbrain's substantia nigra
and the brain stem's pons, respectively). A second PlxnD1+ axonal
pathway (the subiculo-mamillary tract) begins in the subiculum,
transverses the ﬁmbria, fornix and postcommisural fornix to reach the
mammillary bodies in the caudal hypothalamus (Fig. 1J).The axons of these two descending pathways extend near Sema3E-
expressing cells but display sharply different behaviors. The cortico-
fugal and striatonigral axons avoid Sema3E sources (the thalamic
ventricular neurons and the globus pallidus) by growing between
them (through the internal capsule). In contrast, the subiculo-
mammillary axons are attracted to Sema3E and grow along the
axons of Sema3E-expressing neurons of the pyramidal cell layers in
the CA1 and CA3 hippocampal ﬁelds. Notably, the behavior of these
axonal tracts correlates with differences in Nrp1 expression. Nrp1 is
absent in the neurons that interpret Sema3E as a repellent (the
5C.M. Gay et al. / Developmental Biology 349 (2011) 1–19cortifugal and striatonigral tracts) but it is present in the neurons that
sense Sema3E as a chemoattractant (the subiculo-mamillary tract). In
experiments with cultured, dissociated neurons both the repulsive
and attractive effects of Sema3E are PlxnD1-dependent, with Nrp1
enabling or “gating” Sema3E-induced axonal attraction. Remarkably,
Sema3E-induced axonal attraction involves a PlxnD1/Nrp1/VEGFR2
ternary complex in which PlxnD1 functions as the ligand-binding
subunit and VEGFR2 as the signal transducing subunit (Fig. 3D)
(Bellon et al., 2010; Chauvet et al., 2007).
Although the possible link between Sema3E-induced axonal
attraction and p61Sema3E expression has not been explored in this
context, the authors of these studies found that the dual Sema3/VEGF
co-receptor Nrp1 aswell as the VEGF receptor VEGFR2 reduce in half the
numberof Sema3E-binding sites of PlxnD1-expressing cells in vitro. Thus,
the presence of either co-receptor might reduce the access of Sema3E
dimers to PlxnD1 (Bellon et al., 2010; Chauvet et al., 2007) and/or enable
the binding of p61Sema3E monomers, despite the fact that p61Sema3E
does not appear to bind to Nrp1 (Casazza et al., 2010). Interestingly, the
endothelial cell line used to show that p61Sema3E functions as anFig. 3. Sema3/PlxnD1 signaling is capable of promoting attraction and repulsion in both the
Sema3E) is cleaved by a furin-like endoprotease to yield two products. The longer one cont
domain (p25-Sema3E). B, As a result, adenocarcinoma cells secrete three combinations of Se
system (left) full-length Sema3E dimers induce repulsion via PlxnD1. However, the p61-S
endothelial lines expressing PlxnD1 (right). However, the requirement for PlxnD1 tomediate
system, Sema3E acts as a repellant when signaling through PlxnD1 alone (left). However, in
an attractive/growth-promoting axonal response (right). Remarkably, this attractive respon
functioning as the ligand-binding subunit of the complex. In contrast, VEGFR2's intracellular t
however, that the precise Sema3E oligomerization form that mediates these responses is uattractant for endothelial cells is known to express both PlxnD1 and
Nrp1; whether it also expresses VEGFR2 has not been experimentally
veriﬁed (Christensen et al., 2005; Matthies et al., 2002).
Sensory–motor circuit connectivity
Sema3E and PlxnD1 are also key determinants for establishing the
ﬁne synaptic speciﬁcity that matches particular subsets of sensory
afferents (proprioceptive sensory neurons or PSNs) with their cognate
motor neurons (MNs) in two different spinal sensory–motor circuits
of the mouse: the triceps (Tri) and the cutaneous maximus (Cm)
reﬂex arcs (Figs. 2K–L). In the Tri reﬂex arc PSNs provide monosyn-
aptic inputs to MNs. In contrast, Cm's sensory afferents do not synapse
with MNs. The majority of PSNs in both reﬂex arcs express PlxnD1.
However, Sema3e expression is restricted to the Cm's MNs. In a series
of beautiful experiments, the loss of SEMA3E–PLXND1 signaling was
found to induce differential effects on synaptic connectivity. When
either Sema3e or PlxnD1 activity is eliminated, the PSNs and MNs of
the Cm wire together, but Tri PSN–MN connectivity are unaffected.
Conversely, forced SEMA3E expression in Cm MNs prevents PSN–MNvascular and nervous systems. A, In adenocarcinoma cells the full-length Sema3E (p87-
ains the Sema domain (p61-Sema3E) while the shorter one contains the dimerization
ma3E dimers (1–3) and one monomer (4) (Christensen et al., 2005). C, In the vascular
ema3E monomer containing the Sema domain can function as an attractant in some
this attractive response has not been tested (Christensen et al., 2005). D, In the nervous
neurons expressing also Nrp1 and the VEGF receptor VEGFR2, binding of Sema3E elicits
se requires only the extracellular domains of PlxnD1 and Nrp1 (as shown), with PlxnD1
ail is required in this context as the signal transducing subunit (Bellon et al., 2010). Note
nknown.
6 C.M. Gay et al. / Developmental Biology 349 (2011) 1–19connectivity in the Cm arc. Together, these observations indicate that
sensory–motor connectivity is based on a system that employs
SEMA3E-induced, PLXND1-mediated repulsion for blocking synapse
formation (Pecho-Vrieseling et al., 2009; see also Yoshida et al., 2006).
Glandular branching morphogenesis
Formation of the salivary and mammary glands, the lungs and the
kidneys is orchestrated by interactions between epithelial cells
organized in tubular buds and the mesenchyme that surrounds
them, which leads to the growth and branching of the epithelial
primordium (Andrew and Ewald, 2009).
Recently, it was found that epithelial bud cleft formation in the
developing murine submandibular gland (SMG) requires Sema3A,
Sema3C, PlxnD1, PlxnA1 and Nrp1. RNA in situ hybridization reveals
that the transcripts of these ﬁve molecules are expressed within the
epithelial bud during SMG branching morphogenesis. Moreover, loss-
of-function experiments using cultured SMG explants indicate that the
activity of these ﬁve proteins is required for epithelial bud cleft
formation. SMG branching morphogenesis involves cleft formation, a
process that is thought to occur via the local collapse of epithelial cells.
Surprisingly, the canonical PlxnD1 ligand Sema3E (which is expressed
in the epithelial bud) is not required for this process (Chung et al., 2007).
Notably, plxnD1 transcripts are also detected in the mouse
developing mammary gland at the terminal end buds and the stroma
and in the embryonic adrenal gland. Thus, it is likely that PlxnD1 is
involved in the branching of these organs as well (Morris et al., 2006)
(Zhang et al., 2008).
Thymocyte development
Thymocyte maturation requires their proper migration within the
thymus. Repulsive Sema3E–PlxnD1 signaling controls the migration
of CD4+CD8+ double positive (DP) thymocytes. Expression of both
plxnD1 mRNA and PlxnD1 protein is observed in cortical thymocytes
(Fig. 1F). In contrast, Sema3EmRNA is detected in a reciprocal pattern,
at the medulla, where mature CD8+ single positive (SP) thymocytes
(which lack detectable PlxnD1 expression) are located. CCL25–CCR9
chemokine signaling promotes thymocyte migration into the medula.
Thymocyte migration experiments indicate that Sema3E–PlxnD1
signaling inhibits CCL25–CCR9 chemokine signaling, consistent with
the fact that during the DP–SP transition thymocytes downregulate
PlxnD1 expression (Choi et al., 2008). Reduced levels of PlxnD1
expression are also observed in leukemic thymocytes (Calvo, 2005;
Guijosa, 2007).
Sema–PlxnD1 signaling: going new places
plxnD1 is expressed inmany other organs and tissueswhere its role
has not yet been addressed. For example, in themurine podocytes (the
visceral epithelial cells of the kidney that function as the glomerular
ﬁltration barrier), in both the adrenal and mammary glands, the lung
mesenchyme, the ossiﬁcation centers of vertebral bodies (Fig. 1K),
osteoblastic cells and bone tissues of both newborn and adultmice; the
smooth muscle of the small intestine and macrophages (as in
humans). plxnD1 is also prominently expressed in the ﬂoorplate's
hypochord of the zebraﬁsh embryo (Choi et al., 2008; Chung et al.,
2007; Guan et al., 2006; Kanda et al., 2007; Roodink et al., 2008, 2005;
Torres-Vázquez et al., 2004; Zhang et al., 2008) (Morris et al., 2006).
PlxnD1 and disease
Congenital defects: CHARGE syndrome
plxnD1 is necessary for key aspects of murine cardiovascular
development (Gitler et al., 2004; Gu et al., 2005; Zhang et al., 2008).Some of these defects, notably OT abnormalities, are incompatible
with postnatal survival and likely explain why mutations in plxnD1
have not been causally linked to human cardiovascular birth defects.
In contrast, Sema3E-null mice are viable and recapitulate most, but
not all, of the cardiovascular defects observed in plxnD1-deﬁcient
animals (Chauvet et al., 2007; Gu et al., 2005). Accordingly, a missense
mutation in SEMA3E was recently identiﬁed in a patient suffering from
CHARGE syndrome (Lalani et al., 2004). This is a rare and genetically
heterogenous condition named after the constellation of features ﬁrst
used to diagnose it (coloboma of the eye, heart defects, atresia of the
choanae, retardation of growth and/or development, genital and/or
urinaryabnormalities, andear abnormalities anddeafness) (Pagonet al.,
1981). Notably, CHARGE patients and both mouse sema3e and plxnD1
knockouts show parallel abnormalities in the cardiovascular and
nervous systems. Moreover, CHARGE patients and mice lacking
plxnD1 activity display defective skeletal development (Lalani et al.,
2004; Song et al., 2008) (see also http://chargesyndrome.org/about-
charge.asp). Together, these observations suggest that impaired
Sema3E–PlxnD1 signaling is an etiological factor in CHARGE syndrome.
Cancer
Tumors hijack the programs that modulate angiogenesis to gain
the blood supply that enables their survival, growth and metastasis
(Carmeliet, 2005). Recent ﬁndings suggest that Sema3–PlxnD1
signaling antagonizes tumor angiogenesis and tumor development
(Christensen et al., 2005; Roodink et al., 2005). For example, Sema3E
is highly expressed in the melanocytes of early-stage, non-invasive in
situmelanomas but only in 36% of melanoma metastases. In addition,
melanoma cell lines with high Sema3E expression inhibit tumor
angiogenesis in vitro and fail to metastasize in a murine tumor
transplantation model (Kigel et al., 2008; Roodink et al., 2008).
Although these experiments did not address if the Sema3E effects are
PlxnD1-dependent, these results are consistent with the known role
of Sema3E as a PlxnD1-dependent repulsive cue for endothelial cells
duringmammalian embryogenesis (Gitler et al., 2004; Gu et al., 2005).
However, while full-length dimeric forms of Sema3s act as
growth-repelling cues, furin-dependent cleavage of Sema3s reduces
their repelling activity. Consistent with this notion, blocking Furin
activity abolishes the invasiveness and tumorigenicity of human
cancer cells (Adams et al., 1997; Bassi et al., 2001; Klostermann et al.,
1998; Koppel and Raper, 1998). Furin cleaves Sema3E into two
fragments (Fig. 3A). The large one contains the N-terminal Sema
domain, while the short C-terminal fragment includes the Cys residue
involved in Sema dimerization. Thus, furin-induced Sema3E cleavage
generates four Sema3E isoforms of different size and oligomerization
state (Fig. 3B).
Surprisingly, the cleaved Sema3E monomer (p61Sema3E) acts as a
pro–angiogenic attractant in vitro (Fig. 3C), promotes lung metastasis
in mouse xenografts and binds to PlxnD1. In fact, the main Sema3E
isoform secreted by mouse mammary adenocarcinoma cells is
p61Sema3E. Adenocarcinoma cells that lack endogenous sema3E
expression and metastatic potential can form tumors when trans-
fected with vectors that drive the expression of either wild type
sema3E cDNA or an artiﬁcial p61Sema3E isoform (Christensen et al.,
2005). Moreover, in healthy human adults PlxnD1 is expressed only in
very few organs and at low levels. However, the tumor vasculature
and the malignant cells of a wide range of tumors (including both
primary and metastatic brain tumors and melanomas) display
dramatically enhanced PlxnD1 expression. Thus, PlxnD1 is the only
known protein whose expression increases in both tumor compart-
ments: the neoplasm and its vasculature (Roodink et al., 2005, 2009).
Therefore, a recent study analyzed whether the effects of
p61Sema3E on tumor metastasis and tumor angiogenesis are
PlxnD1-dependent. The authors found that in a collection of 60
different human colon carcinoma samples all of them expressed
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was found to be upregulated in colorectal cancer (Galamb et al.,
2008). Interestingly, the ﬁrst study found that Sema3E expression is
selectively enriched in primary tumors associated with metastatic
disease (88%) and in 100% of liver metastases from colon carcinomas.
This indicates that Sema3E and PlxnD1 levels are higher in metastases
than in primary tumors. Similarly, both the level and number of
melanoma cells expressing Sema3E increases with tumor grade
(Casazza et al., 2010). Consistent with this notion another study
reported a parallel trend for PlxnD1 abundance in melanoma
(Roodink et al., 2008). Together, these observations indicate that
increased levels of both Sema3E and PlxnD1 correlate with the
potential for metastatic spreading.
Accordingly, in tumor xenograft assays using mouse hosts
reducing the level of Sema3E or PlxnD1 in the human carcinoma
cells impairs their metastasis without affecting tumor growth.
Conversely, forced expression of either Sema3E or p61Sema3E in
tumor cells increases the incidence of lung metastasis. Indeed,
elevated levels of both Sema3E and PlxnD1 are associated with
enhanced risk for metastatic progression in colon cancer patients.
Interestingly, p61Sema3E–PlxnD1 autocrine signaling in tumor cells
appears to promote tumor metastasis by increasing both tumor cell
migration and extravasation via enhanced extracellular matrix (ECM)
degradation/invasion (Casazza et al., 2010). Finally, it is worth noting
that Sema4D, an alternative PlxnD1 ligand also promotes tumor
development. Sema4D belongs to a class of cleavable transmembrane
Semas that yield soluble forms, further underscoring the importanceFig. 4. Structure of the Sema receptor PlxnD1. A, PlxnD1 is a type I transmembrane protein.
mediating ligand binding. Following the Sema domain there are three MRS (MET-Related
Transcription factors) domains (orange) and the transmembrane domain (brown). The cyto
GAP (GTPase Activating Protein) domain with two highly conserved C regions (C1 and C2; red
includes conserved arginine residues required to inhibit the activity of R-Ras proteins. A Rho
the GAP domain is followed by a short C-terminal region that lacks any resemblance to know
subfamily. Here we designate this region as the terminal (T) segment (pink). The T-segment
with GIPC1. B, Activation model of PlxnD1. In the absence of its Sema ligands, PlxnD1 is in a c
extracellular portion and the GAP domain is non-functional. Upon Sema binding PlexinD
additional protein–protein interactions.of proteolytic cleavage events as determinants for Sema activity
(Basile et al., 2006; Serini et al., 2009; Sierra et al., 2008).
An unhealthy partnership: PlxnD1 and ErbB2
Remarkably, the pro-metastatic effects of p61Sema3E/PlxnD1
require the activity of the oncogenic receptor tyrosine kinase ErbB2
(Erythroblastic leukemia viral oncogene homolog 2). p61Sema3E does
not bind to ErbB2, but rather induces the formation of a phosphotyr-
osinated PlxnD1–ErbB2 complex in human lung carcinoma cells.
Interestingly, each receptor is required for the phosphorylation of the
other: ErbB2 phosphorylation is PlxnD1-dependent and PlxnD1
phosphorylation requires ErbB2's kinase activity. The p61Sema3E–
PlxnD1 mediated metastasis of human lung carcinoma cells is ErbB2-
dependent (Casazza et al., 2010). Consistent with these ﬁndings, ErbB2
induces the expression of the invasion-promoting matrix metallopro-
teaseMT1-MMP(Miyamori et al., 2000).Moreover, knockdownofMT1-
MMP in human ﬁbrosarcoma cells in vitro leads to lower plxnD1 levels
(Rozanov et al., 2008). These observations suggest that p61Sema3E/
PlxnD1/ErbB2 signaling is modulated via positive feedback.
Despite these important advances, key controversies remain.
Studies report opposite correlations between Sema3E abundance
and melanoma and contrasting effects of p61Sema3E on the
chemotactic response of endothelial cells (Christensen et al., 2005)
(Kigel et al., 2008; Roodink et al., 2008) (Casazza et al., 2010).
Undoubtedly future studies will clarify these discrepancies. Nonethe-
less, these observations suggest that targeting Sema–PlxnD1 signaling
could provide the basis for novel anti-cancer therapies.The extracellular N-terminal portion contains a Sema domain (blue), likely involved in
Sequence) repeats (green), four IPT (Immunoglobin-like fold shared by Plexins and
solic tail of PlxnD1 is also known as the Sex and Plexins (SP) domain. It contains a split
). Each C region contains a Ras GAPmotif (RasGAP1 and RasGAP2; black), each of which
-GTPase-binding domain (RBD, beige) is located between the C1 and C2 regions. Finally,
n protein domains and which is highly conserved between members of the same Plxn
of PlxnD1 ends in a short PDZ-binding motif (D1-PBM; aqua) that physically associates
onformationally inactive folded state, in which the Sema domain contacts the rest of the
1 undergoes conformational changes that activate its GAP domain and likely enable
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The view from the outside: the ectodomain
PlxnD1 contains all the domains and motifs generally found in
other Plxns (Figs. 4A, 5A–D). The variably sized (~860–1400 aa)
ectodomain of Plxns contains two regions with homology to the
Sema, MET and integrin protein families. The ﬁrst is the amino-
terminal ~500 aa Sema domain, which displays a seven-bladed Beta-
propeller topology structurally resembling that of integrins. The
second is comprised of three cysteine-rich motifs known as MET-
Related Sequences (MRS repeats or PSI-Plexins, Semas and Integrins-
domains) that are ~50 aa long each. Notably, PlxnD1's third MRS is
atypical because it has six, rather than eight, cysteines. The function of
the MRS repeats is unknown. Finally, the last stretch of the PlxnD1
ectodomain contains four IPT domains (immunoglobin-like fold
shared by Plexins and transcription factor domains; also found in
MET family members). Each IPT domain contains glycine and proline
rich repeats. The role of the IPT domains is unknown, but there is
evidence that they are functionally important: in PlxnA3 a missense
mutation in one of them renders the receptor inactive (Bork et al.,
1999; Tamagnone et al., 1999; Tanaka et al., 2007; van der Zwaag et al.,
2002; Winberg et al., 1998); (Gherardi et al., 2004; Love et al., 2003).
Functions of PlxnD1's Sema domain
Overall, the Sema domain is the extracellular Plxn region that is
best understood. The only demonstrated role for PlxnD1's SemaFig. 5. Sequence conservation of PlxnD1's intracellular domains andmotifs across vertebrates
the arginine residues (outlined in red) essential to functionally antagonize R-Ras family m
highly conserved and show a high degree of similarity to the seven amino acid sequence of
(Hu et al., 2001). D, The PlxnD1-speciﬁc T-segment is highly conserved. It includes an in
interaction between PlxnD1 and the PDZ-containing protein GIPC1. The accession numbers o
chimpanzee/Pan troglodytes (XP_001144444), mouse/Mus musculus (NP_080652), rat/Rattudomain is the physical interaction with the ectodomain of Npns
(Gitler et al., 2004). However, Nrps are not required for Sema3E–
PlxnD1 binding and the PlxnD1–Nrp interaction is Sema3E-indepen-
dent. Nonetheless, the PlxnD1–Nrp1 interaction switches axonal
Sema3E–PlxnD1 signaling from repulsion to attraction during brain
development (Chauvet et al., 2007; Gu et al., 2005).
Studies of other Plxns suggest additional roles for PlxnD1's Sema
domain. These include ligand binding (see Box 1 to learn more about
PlxnD1's ligands and co-receptors), maintaining the receptor in an
inactive state and mediating Plxn–Plxn associations. For example,
ligandbindingbyPlxnB1 requires its Semadomain andotherC-terminal
ectodomain regions (Tamagnone et al., 1999). In addition, a missense
mutation in the Sema domain of PlxnA3 inactivates it (Tanaka et al.,
2007). Accordingly, the extracellular region of mammalian PlxnD1 is
required for Sema3E binding (Gu et al., 2005; Watakabe et al., 2006).
Structure/function studies of PlxnA1 indicate that the association of
the Sema domain with the adjacent C-terminal half of the ectodomain
keeps the receptor inactive. This auto-inhibition is relieved upon ligand
binding, likely via an activating conformational change that extends
into the intracellular domain of the receptor as in Figs. 4A–B. Thus,
PlxnA1 forms lacking either the Sema domain or the entire ectodomain
show constitutive activity (Takahashi and Strittmatter, 2001). Similarly,
PlxnD1 forms without the ectodomain display ligand-independent
constitutive activity in heterologous assays (Uesugi et al., 2008). Finally,
homophilic interactions between the Sema domains of B Plxns appear
to mediate homophilic interactions in cis and cell–cell adhesion in trans
(Hartwig et al., 2005; Ohta et al., 1995).. A, B, The two RasGAPmotifs are 100% conserved amongst the species shown, including
embers via GAP activity and/or sequestration. C, The Rho-GTPase-binding domains are
Drosophila PlxnB (outlined in red) that is required for binding to active, GTP-bound Rac
variable PDZ-binding motif SEA-COOH (outlined in red) that mediates the physical
f the PlxnD1 proteins used for sequence analysis are: human/Homo sapiens (AAI50281),
s norvegicus (NP_001101351) and zebraﬁsh/Danio rerio (AAT64905).
Box 1
PlxnD1 ligands and co-receptors.
Sema3E is the canonical mammalian PlxnD1 ligand. Binding studies with cultured cells and mouse tissue sections indicate that Sema3E
binds to PlxnD1 but not to other Plxns. Typically, type 3 Semas bind and signal via Neuropilin (Npn/Nrp)–Plxn co-receptor complexes
(reviewed in Geretti et al., 2008; Schwarz and Ruhrberg, 2010). Co-immunoprecipitation experiments show that Npn-1 and PlxnD1
associate with each with or without Sema3E and that this interaction requires the Sema domain of PlxnD1. PlxnD1 also associates with
Npn-2. However, Sema3E–PlxnD1 binding is Npn-independent. For example, an Alkaline Phosphatase-Sema3E fusion protein (AP-
Sema3E) binds to COS1 cells expressing PlxnD1, but not to COS1 cells transfected with Npn-1 or Npn-2 expression vectors. Accordingly,
AP-Sema3E binds to COS7 cells and induces their collapse in a PlxnD1-dependent manner. Furthermore, AP-Sema3E still binds to the
endothelium of mouse embryos in which Npn-1 is only available as Npn-1Sema−, an engineered Npn-1 form unable to bind to Sema3s but
which retains VEGF165 binding. Moreover, npn-1Sema−; npn-2 double mutant mice lack Se vessel patterning defects, the hallmark
phenotype of plxnD1 mutants, thus indicating that Sema3E-induced, PlxnD1-mediated endothelial cell repulsion is Nrp1-independent
(Figs. 6A–B). However, although Npn-1 is not required for Sema3E–PlxnD1 binding, in COS7 cells its presence halves Sema3E's Bmax
without affecting Sema3E's binding affinity or PlxnD1's surface levels (Chauvet et al., 2007; Gitler et al., 2004; Gu et al., 2005; Stöhr
et al., 2002; Watakabe et al., 2006). Interestingly, p61Sema3E also binds to PlxnD1 but not to Npn-1 (Casazza et al., 2010).
Neto1 (Neuropilin tolloid-like 1; also known as Btcl1) is a transmembrane protein expressed in the brain and retina with two extracellular
CUB (complement C1r/C1s, Uegf, Bmp1) domains related to those found in Npns and Tolloid (Michishita et al., 2003; Ng et al., 2009) that
like Npns, also associates with PlxnD1. Specifically, Neto1 and PlxnD1 form a Sema3F-specific co-receptor: Neto1 binds to Sema3F only in
the presence of PlxnD1 and associates with PlxnD1 in a Sema3F-dependent manner. Experiments with COS7 cells co-expressing both
Neto1 and PlxnD1 and with explants of Neto1−/− subicular neurons suggest that Sema3F–Neto1/PlxnD1 signaling is repulsive. Notably,
the ectodomain of Neto1 is sufficient to rescue the Sema3F-responsivennes of Neto1−/− subicular neurons. Overall, Neto1 seems to
modulate the ligand-binding specificity of PlxnD1 (Gingrich et al., 2009).
Besides Nrps and Nrp-related proteins, Plxns also associate with other receptors and transmembrane proteins. These include Met/Ron
(Artigiani et al., 2004; Conrotto et al., 2004, 2005; Giordano et al., 2002; Swiercz et al., 2008), OTK/Off-track kinase/, VEGFR2 (Bellon
et al., 2010; Catalano et al., 2009; Toyofuku et al., 2004; Winberg et al., 2001), L1CAM/ L1 Cell Adhesion Molecule (Wang et al., 2008),
TREM/TREM-like receptors (Triggering Receptor Expressed on Myeloid cells) (Ford and McVicar, 2009; Takegahara et al., 2006), ErbB2/
erythroblastic leukaemia viral oncogene homologue 2 (Casazza et al., 2010; Swiercz et al., 2002, 2004) and Abelson 2 (Shimizu et al.,
2008). Some of these Plxn partners also associate with Nrps and/or are active receptor tyrosine kinases (Met/Ron, VEGR2, ErbB2; OTK
lacks tyrosine kinase activity; reviewed in Franco and Tamagnone, 2008). Among these, the only transmembrane proteins known to
associate with PlxnD1 are VEGFR2 and ErbB2. Remarkably, VEGFR2 reduces in half Sema3E's Bmax without affecting Sema3E's binding
affinity or PlxnD1's surface levels (Bellon et al., 2010; Casazza et al., 2010).
Mice lacking the canonical PlxnD1 ligand Sema3E are viable but loss of plxnD1 induces perinatal lethality, suggesting the existence of
additional PlxnD1 ligands (Chauvet et al., 2007; Gu et al., 2005). Accordingly, Sema3C, Sema3F and Sema4A also function PlxnD1
ligands. Sema3C binds to both Npn-1 and Npn-2 directly, but its binding is enhanced by PlxnD1, while Sema4A–PlxnD1 binding is Npn-
independent (Gitler et al., 2004; Toyofuku et al., 2007). Finally, Sema3F specifically binds to PlxnD1/Neto1 co-receptor complexes
(Gingrich et al., 2009).
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N-glycosylation is a common post-translational modiﬁcation that
occurs in the endoplasmic reticulum membrane in which polysac-
charide chains are attached to target proteins. N-glycosylation plays
diverse functions, such as providing speciﬁcity to molecular recogni-
tion events, promoting protein stability and enhancing protein folding
(reviewed in Yan and Lennarz, 2005). The PlxnD1 ectodomain
includes many predicted Asparagine (N)-linked glycosylation sites.
These ﬁt the consensus tripeptide sequon Asn-X-Ser/Asn-X/Thr
(where X is any residue except Pro) (Yan and Lennarz, 2005). The
role that N-glycosylation serves for PlxnD1 is unknown. However, the
glycosylation of Asn500, a predicted N-glycosylation site in hPlxnD1,
has been experimentally conﬁrmed (Liu et al., 2005).
The inside story: the intracellular tail
The ~630 aa cytosolic tail of PlxnD1 resembles that of other Plxns
(Figs. 4A, 5A–D). Plxns contain an intracellular tail with a “Sex and
Plexins” SP domain that harbors two highly conserved C1 and C2
regions (Tamagnone et al., 1999). Collectively, the two C regions are
known as the RasGAP domain because each includes a short motif
with sequence similarity to a group of Guanosine triphosphatase
(GTPase)-Activating Proteins (GAPs) (Figs. 4A, 5A–B) with speciﬁcity
for small monomeric GTPases of the R-Ras subfamily (reviewed in
Pasterkamp, 2005). These two RasGAP motifs (RasGAP1 and
RasGAP2) are the only known homology between Plxns and a
catalytic domain. Each includes conserved R residues essential for
the catalytic activity of RasGAPs. Speciﬁcally, the RasGAP1motif at theN-terminal C1 region includes the invariant R residue found at the
ﬁnger-loop of p120 RasGAP that inserts into the Ras active center. The
RasGAP2 motif in the C2 region includes the R residue that stabilizes
the ﬁnger-loop (Rohm et al., 2000). Notably, Plxns are the only
transmembrane receptors known to directly associate with small
GTPases. A Rho GTPase-Binding Domain (RBD) is sandwiched
between the C regions (Figs. 4A, 5C) (Barberis et al., 2005; Driessens
et al., 2001; Hu et al., 2001; Oinuma et al., 2004a,b; Rohm et al., 2000;
Turner et al., 2004; Vikis et al., 2000; Zanata et al., 2002). The RBD of
Plxns displays a ubiquitin-like fold conformation. In PlxnB1 the RBD
appears to be dimeric. However, in PlxnD1 it appears to bemonomeric
(He et al., 2009; Tong and Buck, 2005; Tong et al., 2007), (http://www.
rcsb.org/pdb/explore.do?structureId=3H6N). Finally, the C2 region of
Plxns is followed by a C-terminal stretch of ~40–60 aa that includes
the COOH terminus and lacks any resemblance to known protein
domains. Here we designate this C-terminal region, which has not
been previously described, as the T-segment (Fig. 5D).
Plxns as RasGAPs
Members of the R-Ras subfamily are GTPases, molecular switches
that oscillate between active (GTP-bound) and inactive (GDP-bound)
states. GAPs inactivate GTPases by increasing their intrinsic rate of
GTP hydrolysis. In the active state R-Ras GTPases enhance integrin-
mediated cell adhesion to the extracellular matrix (ECM; reviewed in
Kinbara et al., 2003).
Accordingly, biochemical assays using cultured neuronal or COS7
cells indicate that Plxns inactivate R-Ras related proteins by acting as
GAPs and that this effect requires the highly conserved R residues found
10 C.M. Gay et al. / Developmental Biology 349 (2011) 1–19at their RasGAP-likemotifs. TheGAPactivity of Plxns abrogates integrin-
mediated cell–ECM adhesion, which in cultured neurons reduces
neurite outgrowth (Ito et al., 2006; Oinuma et al., 2004a, 2006; Rohm
et al., 2000; Uesugi et al., 2008). Ras activity also stimulates
phosphoinositide 3-kinase (PI3K) signaling, amodulator of cell survival,
growth and migration (reviewed in Cantley, 2002). Accordingly,
downregulation of PI3K activity by neuronal Sema–Plxn signaling
(Atwal et al., 2003; Chadborn et al., 2006; Gallo, 2008; Orlova et al.,
2007) requires the RasGAP activity of Plxns, as demonstrated for
Sema4D–PlxnB1 (Ito et al., 2006; Oinuma et al., 2006).
With the exception of PlxnC1, Plxns do not function as constitu-
tively-active GAPs (Uesugi et al., 2008). Instead, expression of the
Plxn's GAP activity requires two events. One of them is Sema binding
to the Plxn ectodomain, which “primes” the receptor likely by
inducing an intracellular conformational change. The second event
is the binding of activated monomeric GTPases of the Rho family (Rac,
Cdc42 and Rnd subfamilies; Rho-like GTPases or RLGs) to the RBD.
RBD–RLG binding disrupts the inhibitory association between the C1
and C2 regions, thus enabling the GAP activity of Plxns.
In some Plxns the RBD also plays a second role, that of preventing
the bound RLG from interacting with its downstream effectors. For
example, in ﬂy PlexB the physical interaction of the RBD with GTP-
bound Rac/Cdc42 (RacGTP) sequesters RacGTP away from its effector
p21-activated kinase (PAK), thus blocking PAK activation. This
antagonizes the stabilization of actin ﬁlaments and promotes
neuronal growth cone collapse (Barberis et al., 2005; Driessens
et al., 2001; Hu et al., 2001; Oinuma et al., 2004a,b; Rohm et al., 2000;
Turner et al., 2004; Vikis et al., 2000; Zanata et al., 2002).
PlxnD1 has GAP activity
Several observations indicate that similar to other Plxns, PlxnD1
acts as a RasGAP to antagonize both integrin-mediated cell–ECM
adhesion and PI3K signaling. For instance, Sema3E treatment of
cultured endothelial cells decreases the phosphorylation of Focal
Adhesion Kinase (FAK), a key molecule that regulates the turnover of
integrin-containing focal adhesions. In addition, Sema3E-treated COS-7
cells grown on integrin ligands such as collagen or ﬁbronectin,
collapseif transfectedwithconstructsfortheexpressionofwildtype
PlxnD1. Incontrast,COS-7cellsgrownonpoly-L-lisineorexpressing
PlxnD1 forms with mutated RasGAP motifs fail to collapse upon
Sema3E treatment (Sakurai et al., 2010). In addition, unpublished
evidence suggests that repulsive Sema3E–PlxnD1 signaling in
neuronsdownregulatesPI3KactivityinaRasGAP-dependentmanner
(Eickholt,2008).
Activation of the RasGAP activity of PlxnB1 and PlxnA1 requires
RLGs of the Rnd subfamily, which are unique in that they exist in a
constitutively-active GTP-bound state due to their lack of intrinsic
GTPase activity (Foster et al., 1996; Ito et al., 2006; Nobes et al., 1998;
Oinuma et al., 2003, 2004a, 2006; Tong et al., 2007; Toyofuku et al.,
2005). Therefore, the ability of Rnd1, 2 and 3 to bind to the
intracellular tail of murine PlxnD1 (mPlxnD1) was recently tested.
Extracts from transfected COS-7 cells indicate that these three Rnds
can bind to PlxnD1. However, Rnd2 (Rho7/RhoN/ARHN) exhibits
preferential PlxnD1 binding. The Rnd2-binding region of PlxnD1maps
to the N-terminal half of the cytosolic tail, which contains both the C1
region and the RBD. Hence, these observations suggest that the
PlxnD1–Rnd2 physical interaction is mediated by PlxnD1's RBD.
Moreover, different lines of evidence support the idea that Rnd2 is
required for the activation of the RasGAP activity of PlxnD1 in vivo.
First, Sema3E blocks axon elongation in cultured cortical neurons in
an Rnd2-dependent manner. Second, endogenous PlxnD1–Rnd2
complexes can be isolated from these cells via co–immunoprecipita-
tion (Uesugi et al., 2008). Additional observations provide insights
into the molecular mechanisms by which Rnd proteins might
modulate PlxnD1 function. First, formation of a PlxnD1–Rnd2
complex occurs even without Sema3E stimulation in transfectedCOS-7 cells. Second, formation of a PlxnD1–Rnd2 complex does not
result in the expression of PlxnD1's GAP activity. Third, the GAP
activity of a membrane-targeted form of PlxnD1 lacking its extracel-
lular domain is Sema3-independent but Rnd2-dependent (Uesugi
et al., 2008).
There are conﬂicting reports about the effects of p61Sema3E on
endothelial cell migration (Christensen et al., 2005) (Kigel et al., 2008;
Roodink et al., 2008) (Casazza et al., 2010). Nonetheless, it is
interesting to note that p61Sema3E provided by human carcinoma
cells inhibits tumor vascularization by the murine hosts. Accordingly,
p61Sema3E collapses and inhibits the migration of HUVECs (Human
Vein Endothelial Cells) in a manner that requires both PlxnD1 and
Rnd2 (Casazza et al., 2010; Gitler et al., 2004). Thus, these experiments
suggest that Sema3E and p61Sema3E-induced cell repulsion are
Rnd2-dependent.
Sema3E, the canonical ligand for mammalian PlxnD1, induces both
repulsive and attractive responses in axons (Fig. 3D) (Bellon et al.,
2010; Chauvet et al., 2007). Interestingly, Rnd2 alsomediates opposite
effects in neuronal morphology. Rnd2's differential effects depend on
its choice of partner. Rnd2 can bind to Pragmin (pragma for Rnd2), a
neuronal molecule that can associate with RhoA simultaneously.
Pragmin promotes Rho activity to stimulate cell contraction via a
poorly deﬁned non-GEF mechanism (Govek et al., 2005; Tanaka et al.,
2006). However, Rnd2 is also capable of binding to Rapostlin (apostle
of Rnd2), a microtubule-binding protein. Rapostlin induces neurite
branching in PC12 cells in the presence of constitutively-active Rnd2
(Fujita et al., 2002). These observations suggest that Rnd2 might be
involved in both repulsive and attractive responses downstream of
Sema3E. However, it is unlikely that Sema3E-induced axonal
attraction/growth requires a PlxnD1–Rnd2 interaction, since these
effects are independent of the intracellular tail of PlxnD1 (Bellon et al.,
2010). Nonetheless, the factors that modulate Rnd2's choice of
partner, whether Pragmin or Rapostlin associate individually and/or
simultaneously with PlxnD1-bound Rnd2 in vivo and the precise role
of these interactions remain unexplored.
The substrate speciﬁcity of PlxnD1's GAP activity was recently
explored using COS-7 cells transfected with two different R-Ras
subfamily members, TC21 and M-Ras. Under these conditions PlxnD1
exhibits Rnd2-dependent GAP activity only towards M-Ras (Uesugi
et al., 2008). This suggests that M-Ras is involved in Sema3E–PlxnD1
signaling in the brain (Bellon et al., 2010; Chauvet et al., 2007), since
M-Ras is predominantly expressed in the CNS (Kimmelman et al.,
1997). However, given PlxnD1's prominent role in cardiovascular
development (Gitler et al., 2004; Gu et al., 2005; Torres-Vázquez et al.,
2004; Zhang et al., 2008) another likely substrate for PlxnD1's GAP
activity is R-Ras, which is enriched in endothelial cells (Komatsu and
Ruoslahti, 2005). However, the involvement of R-Ras in Sema–PlxnD1
signaling has not been directly tested.
Finally, it is possible that PlxnD1 antagonizes the activity of R-Ras
family members non-catalytically, by sequestering them in a manner
that still requires the RasGAP1/2 motifs (Sakurai et al., 2010).
A general model for Sema–PlxnD1 signaling
Based on the above observations we propose the following model
(Figs. 6A–B). Upon Sema3E stimulation PlxnD1 in pre-existing
PlxnD1–Rnd2/RLG complexes undergoes an Rnd2/RLG-dependent
intracellular conformation change that translates the concentration
and distribution of extracellular Sema3 cues into an intracellular
gradient of distinct PlxnD1 activities.
In cells interpreting Sema cues as repulsive, such as endothelial
cells and neurons (Bellon et al., 2010; Chauvet et al., 2007; Gitler et al.,
2004; Gu et al., 2005; Torres-Vázquez et al., 2004; Zhang et al., 2008),
these activities would be the RasGAP1/2-dependent inhibition of
members of the R-Ras subfamily to antagonize integrin-mediated
adhesion, PI3K signaling and the RhoA/Pragmin dependent collapse of
the cytoskeleton.
Fig. 6. A general model of Sema3/PlxnD1-mediated repulsion. A, In the absence of ligand-mediated activation PlxnD1 is in a conformation that enables its association with GTP-
bound Rnd2 but prevents its interaction with active, GTP-bound Rac and R-Ras. Thus, GTP-bound Rac is able to bind to PAK (p21-activated kinase) to stimulate the assembly of actin
ﬁlaments to support cell migration while active GTP-bound Ras promotes integrin-mediated adhesion to the extracellular matrix (ECM) and mediates additional downstream
signaling events. B, Upon binding of its Sema3 ligand, PlxnD1 undergoes a conformational change and binds the active forms of both Rac and R-Ras GTPases. By sequestering Rac,
PlxnD1 leads to the inactivation of PAK and the collapse of the actin-based cytoskeleton leading to retraction and/or turning responses. PlxnD1 inactivates R-Ras GTPases by either
enhancing GTP hydrolysis (as shown) or by sequestering them resulting in the loss of integrin-based adhesion to the ECM (Ito et al., 2006; Oinuma et al., 2004a, 2006; Rohm et al.,
2000; Sakurai et al., 2010; Uesugi et al., 2008) and likely reducing as well other R-Ras mediated signaling events.
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for some mammalian axon tracts, the intracellular domain of PlxnD1
is not required, thus indicating that this effect is mediated by a
different molecular mechanism. Indeed, it was recently shown that
Sema3E-induced axonal attraction/growth occurs via a PlxnD1/Nrp1/
VEGFR2 trimeric complex that increases PI3K signaling in a VEGFR2-
dependent manner (Bellon et al., 2010; Chauvet et al., 2007; Eickholt,
2008; Sakurai et al., 2010). Whether the same mechanism is
responsible for the pro-angiogenic effects of speciﬁc Sema3E isoforms
secreted by some tumors (see Christensen et al., 2005) or whether
these effects are promoted by the simultaneous interaction of Rnd2/
RLGs with both PlxnD1 and with Rapostlin—or a functionally similar
molecule—remains to be elucidated.
Sema–Plxn signaling: output speciﬁcity
The inactivation of R-Ras related proteins and the regulation of
cytoskeletal dynamics are common Plxn outputs. Yet each Plxn plays
seemingly distinct biological roles. This is likely due to the unique
expression pattern of each Plxn, their differential ligand speciﬁcity
and/or afﬁnity and the speciﬁc pathway repertoire active in each
tissue. However, another key contributing factor is that individual
Plxns also engage speciﬁc suites of modulators and/or effectors via
subfamily-speciﬁc intracellular binding motifs. For instance, B Plxns
contain additional motifs between their C1 and C2 regions besides the
short RBD shared by all Plxns: Drosophila PlxnB binds and promotes
RhoA activity via a 40 aa motif that is absent from other Plxnsubfamilies (Hu et al., 2001). Similarly, both human PlxnB1 and B2
contain a Cdc42/Rac interactive binding-like motif (CRIB-LM) that
binds active Rac in a ligand-dependent manner (Vikis et al., 2000). In
contrast, PlxnA1, A2 and D1 lack a CRIB-LM and do not bind to active
Rac in vitro (Driessens et al., 2001) (see also Turner et al., 2004).
Moreover, except for the RBD, the sequence between the halves of the
SP domain is poorly conserved across Plxn subfamilies. Hence, novel
subfamily-speciﬁc molecular determinants of Plxn activity are likely
to reside here.
The T-segment is a candidate region for providing signaling
speciﬁcity to each Plxn. We have found through sequence compar-
isons that T-segments are highly conserved within Plxn subfamilies
but very dissimilar across subfamilies. Thus T-segment sequence
conservation parallels that of the ectodomains, the criteria for Plxn
subfamily classiﬁcation (see Tamagnone et al., 1999). For example, the
only signiﬁcant hits obtained by BLASTing (McGinnis and Madden,
2004) the ~37 aa T-segment of hPlxnD1 are the T-segments of PlxnD1
proteins from mammals, birds, amphibians and ﬁsh, which are 94–
100% identical and 100% similar. In contrast, the T-segment of
hPlxnD1 lacks any similarity with that of PlxnC1 and is only 25–53%
identical and 45–69% similar to the T-segments of A and B Plxns.
Accordingly, in B Plxns the T-segment terminates in a short
protein–protein interaction motif that mediates binding to the PDZ
(PSD-95, Dlg, ZO-1) domain of Leukemia-Associated Rho Guanine
exchange factor (LARG or PDZ-RhoGEF/Leukemia). This PDZ-
binding motif (B-PBM) seems to be essential for LARG binding,
since Plxns from the other three subfamilies lack this motif and
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of LARG is essential for the ability of B Plxns to activate RhoA
(Aurandt et al., 2002; Driessens et al., 2002; Hirotani et al., 2002;
Hu et al., 2001; Oinuma et al., 2003; Perrot et al., 2002; Swiercz
et al., 2002).
PlxnD1 contains a unique binding motif in its T-segment
By comparing the sequence of Plxn T-segments we uncovered a
highly conserved, PlxnD1-speciﬁc C-terminal sequence similar to a
motif (S/T-X-A/V/L/I) known for binding to proteins containing a PDZ
type I domain (De Vries et al., 1998; Hu et al., 2003; reviewed in Jeleń
et al., 2003). We thus refer to this sequence as the D1-PBM (PlxnD1
Box 2
Other potential intracellular effectors/modulators of PlxnD1.
GIPC1 is a scaffolding protein that associates with many single-pas
example, GIPC1 binds to the cytosolic tail of Nrp1 via its C-terminal P
between Nrp1 and VEGFR2 and enhances VEGF-induced angiogenesis.
1999; Chittenden et al., 2006; Lanahan et al., 2010; Ren et al., 2010
Remarkably, we isolated the entire gipc1 cDNA twice as a prey in a yea
tail. We have found that the PlxnD1–GIPC1 interaction is mediated b
located in the T-segment and is identical to the Nrp1 motif (Brant Wein
see also Linhares and Gutkind, 2005). These observations suggest t
specifically modulating Sema3–PlxnD1 signaling or enabling the inte
potential importance of GIPC1 in the context of Sema–PlxnD1 signaling
existence of alternatively spliced plxnD1 isoforms in human and chimp
predicted PlxnD1 variants is the substitution of the D1-PBM for a 43
observations suggest that PlxnD1's T-segment engages unique effect
The MICALs (fromMolecule Interacting with CasL) (Suzuki et al., 2002
redox activity expressed in the vertebrate and Drosophila nervous syst
and the C-terminal coiled-coil domain (cc) of fly MICAL binds to a frag
(Terman et al., 2002). MICAL also binds to cytoskeletal components,
proteins (Kolk and Pasterkamp, 2007). In flies Sema-1a/1b-PlexA sig
modulate the morphology of bristle and axon growth cones (Hung e
involves direct REDOX modification of its substrates or occurs via the
Kolk and Pasterkamp, 2007).
The MICAL-like proteins are structurally similar to MICALs but lack
destabilization (Hung et al., 2010; Terman et al., 2002). MICAL-like p
Interestingly, MICAL-like proteins associate with actin-binding prote
cytoskeleton during neurite outgrowth (Sakane et al., 2010), promote
Plxns, including PlxnD1, are expressed, such as the nervous (Terman
proteins have been implicated in the endocytic recycling of some transm
they might exert a similar effect on Plxn receptors.
The Collapsin ResponseMediator Proteins (CRMPs) is a family of tetram
as positive effectors of repulsive Sema-PlxnA signaling. Despite seque
dependent amidohydrolases CRMPs lack enzymatic activity. Biochemi
and suggests that they link Plxn signaling with membrane endocytosis
2007; Shih et al., 2003).
Nervy belongs to the Myeloid Translocation Gene (MTG) family of A k
CNS and associates with the intracellular region of fly PlexA containin
negative cytosolic regulator of Sema1a/PlxnA-induced axonal repulsion
dependent protein kinase A (PKA) (Terman and Kolodkin, 2004). Indeed
and the vertebrate Nervy homologue MTG16b specifically interacts ph
Themechanism bywhich Nervy antagonizes PlxnA signaling remains co
translocation genes MTG8/ETO, MTG16 and MTGR1) also localize to t
possibility that Nervy's effects on Sema–Plxn signaling have a transc
2005).
Arf6 (ADP-ribosylation factor 6) is a small GTPase that regulates both c
well as actin and membrane remodeling (reviewed in D'Souza-Schorey
the trafficking of β1 integrins, which play important roles in angiog
adhesion and migration (Dunphy et al., 2006; Mettouchi and Meneg
signaling reduces endothelial cell adhesion to the ECM by promoting the
structures. These effects seem to be in part related to the activation of A
Arf6 levels in a manner that requires the RasGAP motifs of PlxnD1. C
Sema3E/PlxnD1-mediated cell collapse. However, the mechanistic link
there is no evidence supporting a direct physical interaction between APDZ-binding motif; Figs. 4A, 5D). The consensus D1-PBM sequence,
derived from the PlxnD1 proteins of ﬁsh, amphibians, birds and
mammals, is SEA-COOH. Importantly, we found that the D1-PBM is
essential for PlxnD1's ability to physically associate with the PDZ
domain of GIPC1 (GAIP Interacting Protein, C terminus; also known as
Synectin among many other names) (Carl M. Gay, Brant M. Weinstein
and Jesús Torres-Vázquez; unpublished observations, see also
Linhares and Gutkind, 2005). GIPC1 is an intracellular protein that,
like PlxnD1, plays key roles during angiogenesis (Cai and Reed, 1999;
Chittenden et al., 2006; Lanahan et al., 2010; Ren et al., 2010; Wang
et al., 2006). Thus it is likely that GIPC1 functions as a PlxnD1-speciﬁc
modulator/effector (see Box 2).s type I transmembrane proteins via its central PDZ domain. For
DZ-binding motif SEA-COOH. This event promotes the association
For example, gipc1morphants display stunted SeAs (Cai and Reed,
; Wang et al., 2006).
st-two-hybrid screen for proteins that bind to the PlxnD1 cytosolic
y GIPC1's PDZ domain and PlxnD1's PDZ-binding motif, which is
stein, Carl M. Gay and Jesús Torres-Vázquez, unpublished results,
hat GIPC1 might play additional roles in the vasculature, such as
gration of Sema3–PlxnD1 and VEGF-Nrp1/VEGFR2 signals. The
is further underscored by bioinformatic predictions that suggest the
anzee. Among the various sequence changes that distinguish these
aa stretch without identifiable PDZ-binding motifs. Overall, these
ors/modulators, including GIPC1, to fulfill its biological roles.
) are a family of multidomain cytosolic proteins with flavoenzymatic
ems. Fly MICAL is required for axonal repulsion by Sema-1a/PlexA
ment of fly PlexA containing both the C2 region and the T-segment
small GTPases and to CRMPs, another group of A Plxn associated
naling binds and destabilizes F-actin via MICAL's redox activity to
t al., 2010). However, whether MICAL's oxidoreductase activity
generation of reactive oxygen species remains unclear (reviewed in
the monooxygenase domain required for MICAL-mediated F-actin
roteins have a cc domain, but it is not known if they bind to Plxns.
ins (Nakatsuji et al., 2008), function as modulators of the actin
cell migration (Kanda et al., 2008) and are found in tissues where
et al., 2002) and vascular systems (Weber et al., 2005). MICAL-L
embrane proteins (Sharma et al., 2009; Terai et al., 2006) and thus
eric phosphoproteins expressed in the nervous system that function
nce and structural similarities with dihydropyrimidinases and metal-
cal evidence indicates that CRMPs interact physically with MICALs
during growth cone steering (reviewed in Schmidt and Strittmatter,
inase Anchoring Proteins (AKAPs). It is expressed in the Drosophila
g the C2 region and the T-segment. Nervy is postulated to act as a
by linking PlxnAwith the cAMP (cyclic adenosinemonophosphate)-
, vertebrate PlxnA1 and PlxnA3 are phosphorylated in vitro by PKA
ysically with Plxns A1 and A3 but not PlxnB1 (Fiedler et al., 2010).
ntroversial because Nervy and its vertebrate homologs (the myeloid
he nucleus and act as transcriptional co-repressors, thus raising the
riptional basis (Terman and Kolodkin, 2005; Wildonger and Mann,
lathrin-dependent and clathrin-independent endocytic pathways as
and Chavrier, 2006). Accordingly, Arf6 has been shown to regulate
enic development. Moreover, downregulation of Arf6 impairs cell
uzzi, 2006; Powelka et al., 2004). Interestingly, Sema3E–PlxnD1
disassembly of focal adhesions, which are integrin-based adhesive
rf6, since Sema3E–PlxnD1 signaling in COS-7 cells elevates active
onversely, in COS-7 cells a dominant negative form of Arf6 blocks
between R-Ras inhibition and Arf6 activation remains unclear and
rf6 and PlxnD1 (Sakurai et al., 2010).
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Besides Rnd2, M-Ras (Uesugi et al., 2008) and GIPC1 (Carl M. Gay,
Brant M. Weinstein and Jesús Torres-Vázquez; unpublished observa-
tions; Linhares and Gutkind, 2005), the other intracellular proteins
that associate with the cytosolic tail of PlxnD1 are ACF7 (Actin Cross-
linking Family Protein 7), FLNA (Filamin A) and CKAP1 (Cytoskeleton
Associated Protein 1). These three candidate PlxnD1 effectors/
modulators are the ﬁrst cytoskeletal proteins known to interact
directly with any Plxn (see Box 3).
Hence, unraveling the role of these proteins as well as those of
other candidate intracellular effectors/modulators of PlxnD1 such as
the MICALs, MICAL-like proteins, CRMPs and the vertebrate homologsBox 3
Cytoskeletal proteins that interact physically with PlxnD1.
ACF7 is a large spectraplakin cytoskeletal crosslinking protein. It co
Calponin-homology (CHD) domains and a plakin-like globular domain.
spectrin repeats and an active ATPase region. Finally, the C-termin
microtubule-binding region with homology to Gas2 (growth arrest-s
Karakesisoglou et al., 2000; Leung et al., 1999; Sawamura et al., 1990
in a large yeast-two-hybrid screen for interactions between the cytos
human proteins. Specifically, a bait containing aa 1352–1985 of hPlxn
2002) (see also http://www.kazusa.or.jp/huge/ppi/), suggesting PlxnD
In themurine skin epidermis ACF7 coordinates the growth of microtubu
their turnover during cell migration (Leung et al., 1999; Wu et al., 200
expressed in many murine embryonic tissues, including the nervous
endothelium, since its transcription is upregulated in human coronary
2008). Thus, it seems likely that ACF7 and plxnD1 are co-expressed in
PlxnD1-mediated cytoskeleton modulation.
FLNA is a large cytoplasmic, non-muscle actin-binding protein that f
filaments into a dynamic orthogonal network. Like ACF7, its N-terminu
repeat modules of ~100 aa which together form two rod domains joi
binds more than 30 other partners, including PlxnD1 (via modules 10 an
integrins and Rho family GTPases. FLNA's repeats function as protei
subgroups with presumably distinct ligand-binding specificity. It has
scaffold for clustering interacting receptors and their effectors at the ce
Thus, it is tempting to speculate that FLNA serves to bring together Plxn
2007; Ithychanda et al., 2009; Popowicz et al., 2006; Robertson, 20
FLNAmutations are associated with human genetic diseases characteriz
cardiovascular systems (reviewed in Popowicz et al., 2006; Roberts
transcripts are enriched in the endothelium and the heart's endocardial c
die at midgestation and display massive hemorrhage, misguided Se v
Notably, the cardiovascular defects of FLNA null mouse embryos paral
et al., 2005; Zhang et al., 2008), consistent with the putative involve
CKAP1 is a widely expressed 250 aa protein whose relatives are impli
storage, dissociation and degradation. It is abundant in neuroblasts and
terminal ubiquitin (UBL)-like domain, a central coiled-coil region and a
domain. CAP-Gly domains are common in proteins that bind to the C-te
is controversial) and also mediate other protein–protein interactions and
polarity (Grynberg et al., 2003; Kortazar et al., 2007; Lopez-Fanarraga
2005). Notably, several lines of evidence implicate CKAP1 in the mod
over-expression of murine CKAP1 promotes microtubule depolymeriza
microglia are associatedwith lowmicrotubule densities (Fanarraga et al
that targets CKAP1 for degradation induce giant axonal neuropathy (G
microtubule depolymerization, growth cone retraction, axonal dama
reducing CKAP1 levels in cultured neurons enhances axonal growth (Lo
of CKAP1 modulates microtubule growth (Vadlamudi et al., 2005). W
that bind to the cytosolic tail of murine PlxnD1 (Carl M. Gay, Brant M. W
was also found in a similar screen using PlxnA1's C1 region as bait. Th
the C1 region of Plxns in microtubule regulation (Togashi et al., 200
signaling is consistent with other observations, including the role of PA
et al., 2001; Rohm et al., 2000; Vikis et al., 2000) in modulating CKAP1
Sema and tubulin abundance in human ovarian adenocarcinoma cell li
zebrafish embryonic tissues where PlxnA1 and/or PlxnD1 are also expre
Overall, the identification of intracellular PlxnD1-binding proteins repre
transforms Sema cues into intracellular signals. Future studies will eluci
and uncover the significance of other candidate PlxnD1 effectors/modof Drosophila Nervy (see Box 2) will likely provide key insights into
the molecular mechanisms by which chemotactic Sema–PlxnD1/Plxn
signalingmodulates cytoskeletal dynamics to guide cell migration and
induce cell shape changes.
Post-translational Plxn modiﬁcations: phosphorylation
Plxns are tyrosine phosphorylated at their cytosolic tails
Although Plxns lack intrinsic kinase activity they are phosphory-
lated at cytosolic tyrosine residues in vivo (Tamagnone et al., 1999).
Tyrosine phosphorylation is a key regulatory protein modiﬁcation
made by both receptor and non-receptor tyrosine kinases. It createsntains an N-terminal head domain with two actin-binding (ABD)
Its central region includes a rod domain with many dystrophin-like
us harbors two putative calcium-binding EF-hand motifs and a
pecific protein 2/GAR) (Bernier et al., 1996; Byers et al., 1995;
; Sun et al., 1999). ACF7was identified as a PlxnD1-binding protein
olic tails of large transmembrane human brain proteins and other
D1 trapped an N-terminal 317 aa ACF7 fragment (Nakayama et al.,
1's cytosolic tail binds to ACF7's ABDs.
les along F-actin by directing them to focal adhesions and enhancing
8). ACF7 also promotes Wnt signaling (Chen et al., 2006). ACF7 is
system (Bernier et al., 2000) and is also likely expressed in the
artery endothelial cells by laminar shear stress (Chu and Peters,
some tissues, consistent with the potential involvement of ACF7 in
orms filamentous v-shaped dimers which cross-link cortical actin
s contains two CHDs and an ABD, which is followed by 24 Filamin
ned by a pair of flexible hinge regions. In addition to F-actin, FLNA
d/or 11) as well as other molecules implicated in Plxn signaling, like
n–protein interaction modules that belong to four sequence-based
been suggested that this property enables FLNA to function as a
ll surface and link their activity to the regulation of the cytoskeleton.
D1with its effectors/modulators (Feng andWalsh, 2004; Horowitz,
05; Stossel et al., 2001; see also Lu et al., 2007).
ed by abnormalities in the development of the nervous, skeletal and
on, 2005). In the murine embryonic cardiovascular system FLNA
ushion, outflow tract and cardiac valves. FLNA null mouse embryos
essels, PTA and incomplete cardiac septation (Feng et al., 2006).
lel those found in mouse plxnD1 knockouts (Gitler et al., 2004; Gu
ment of FLNA in PlxnD1 signaling.
cated in tubulin dynamics, such as folding, heterodimer formation,
enriched at the growth cone transition zone. CKAP1 contains an N-
C-terminal cytoskeleton-associated protein glycine-rich (CAP-Gly)
rminus of alfa-tubulin (although CKAP1's ability to bind alfa-tubulin
regulate intracellular signaling, vesicle transport, cell migration and
et al., 2007; Steinmetz and Akhmanova, 2008; Vadlamudi et al.,
ulation of microtubule dynamics and axonal growth. For example,
tion (Kortazar et al., 2007) and high CKAP1 levels in macrophage/
., 2009). Similarly, mutations in gigaxonin, a CKAP1-binding protein
AN) disorder. This disease features high levels of neuronal CKAP1,
ge and neuronal degeneration (Wang et al., 2005). Conversely,
pez-Fanarraga et al., 2007) and the PAK-mediated phosphorylation
e isolated mouse CKAP1 in a yeast-two-hybrid screen for proteins
einstein, and Jesús Torres-Vázquez; unpublished results). CKAP1
is screen yielded other microtubule-regulating proteins, implicating
6). The potential involvement of CKAP1 in PlxnD1 and/or PlxnA1
K, whose activity is antagonized by Sema–Plxn signaling (Driessens
function (Vadlamudi et al., 2005), the inverse correlation between
nes (Prislei et al., 2008) and the prominent expression of ckap1 in
ssed (Carl M. Gay and Jesús Torres-Vázquez; unpublished results).
sents the first step towards a molecular understanding how PlxnD1
date the role that these proteins play during PlxnD1 signaling in vivo
ulators (see Box 3).
Table 1
Conservation of tyrosine residues in the cytoplasmic tail of PlxnD1 proteins.
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Table 2
Conservation of predicted PKA phosphorylation sites (S/T) in PlxnD1's intracellular tail.
Human T1486 S1488 S1693 S1709 S1766 T1901
Mouse T1486⁎ S1488 S1693 S1709 S1766 T1901
Chicken T1489 S1491 S1696 S1712 S1769 T1889
Xenopus T1087 S1089 S1294 S1310 S1367 T1502
Zebraﬁsh T1441 S1443 S1648 S1664 S1721 T1856
Notes: PKA phosphorylation sites were predicted using the pkaPS server (http://
mendel.imp.ac.at/sat/pkaPS/). The accession numbers of PlxnD1 proteins are as
follows: Human (NP_055918), mouse (NP_080652), chicken (XP_414455), Xenopus
(AAI68545, partial sequence), zebraﬁsh (AAT64905.1). *Murine PlxnD1 residue T1486 is
conserved but not a predicted PKA target.
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(PhosphoTyrosine-Binding) domains for the downstream activation
of the Ras/ERK MAP and the PI3K cascades. It also leads to the
recruitment of proteins with PTP (Protein Tyrosine Phospatase)
domains. PTP-containing proteins that are catalytically active de-
phosphorylate regulatory tyrosine phosphates while those that are
catalytically dead engage in phosphotyrosine-recognition to mediate
scaffolding and localization functions (reviewed in Hunter, 2009;
Moorhead et al., 2009).
PlxnD1 is also tyrosine phosphorylatedand contains unique tyrosine residues
Members of the four Plxn subfamilies share thirteen conserved
intracellular tyrosines. Except for the fourth one, which is in the RBD,
all of them are found in the SP domain. The corresponding residues in
human PlxnD1 (hPlxnD1) are listed in Table 1 and shown in a
sequence context in Figs. 5A–D (Franco and Tamagnone, 2008).
Inaddition, eleven tyrosine residues are conserved across the PlxnD1
proteins of mammals, birds, amphibians and ﬁsh (Table 1 and Figs. 5A–
D). Six of them are PlxnD1-speciﬁc (in hPlxnD1: Y1367, Y1371, Y1618,
Y1673, Y1919 and Y1922; see Table 1 and Sulka et al., 2009). The latter
two are in the T-segment; Y1371 is absent from ﬁshes. The remaining
ﬁve tyrosines are sharedwith one (Y1303, Y1459, Y1597, Y1864) or two
(Y1503) Plxn subfamilies (hPlxnD1 positions). Conversely, PlxnD1
proteins lack tyrosine residues that are highly conserved in other Plxn
subfamilies. An example is Y1708, which appears to be speciﬁc for B
Plxns (see Franco and Tamagnone, 2008; Swiercz et al., 2009).
Overall, many of the conserved tyrosine residues in PlxnD1
proteins reside within sequence contexts predicted to be substrates
for tyrosine kinases (both receptor and non-receptor) and phospha-
tases (Amanchy et al., 2007). Some of these sequences also match the
consensus binding sites for known protein–protein interaction
modules, such as those of adaptor proteins, which might enable
cross talk and/or integration between Sema–PlxnD1 signaling and
other cascades (see Table 1). Importantly, tyrosine phosphorylation of
PlxnD1 has been experimentally conﬁrmed in the human and mouse
proteins for two residues: the PlxnD1-speciﬁc Y1367 and Y1642,
which is located at the RBD and conserved across Plxn subfamilies
(http://www.phosphosite.org, http://www.abgent.com/products/cat-
alog_no/AP3584a/speciﬁcation, Franco and Tamagnone, 2008).
Plxns associate with tyrosine kinases
Plxns lack kinase activity but are phosphotyrosine proteins.
Accordingly, they form complexes with both receptor and non-
receptor tyrosine kinases (reviewed in Franco and Tamagnone, 2008).
For example, ErbB2 phosphorylates PlxnB1 at both Y1708 (a PlxnB-
speciﬁc residue) and at Y1732 (one of the thirteen tyrosines
conserved across Plxns), while c-Met phosphorylates other PlxnB1
tyrosine residues. In particular, the phosphotyrosines Y1708 and
Y1732 serve as docking sites for the SH2 domains of phospholipase
Cγ (PLCγ), which in a lipase-independent manner activates RhoANotes to Table 1:
NOTES: In the ﬁrst column (Y) residues highlighted as follows: red (conserved across Plxn s
(shared with two Plxn subfamilies). In the Score column, scores above the prediction thresh
K (PPSP, Prediction of Protein kinase-Speciﬁc Phosphorylation site; http://ppsp.biocucko
Finder; http://www.hprd.org/PhosphoMotif_ﬁnder) and S (Scansite; http://scansite.mit.e
(anaplastic lymphoma receptor tyrosine kinase), BTK (Bruton agammaglobulinemia tyrosin
adhesion kinase), FES (feline sarcoma oncogene), FGFR (ﬁbroblast growth receptor), FGR (G
virus integration site 2 homolog/colony-stimulating factor 1 receptor or CSF1R), FYN (proto
JAK2 (Janus kinase 2), MET (met proto-oncogene/hepatocyte growth factor receptor), PD
sarcoma viral oncogene homolog), SYK (spleen tyrosine kinase), TIE2 (TEK tyrosine kinase)
protein tyrosine phosphatase, non-receptor type 1), SHP1 (src homology region 2 domain-c
protein tyrosine phosphatase, non-receptor type 2). pY context matches binding motif for: S
murine leukemia viral oncogene homolog 1), Cbl (Casitas B-lineage lymphoma), Crk (v-c
Receptor Interacting Protein's phosphotyrosine-binding domain), FYN (proto-oncogene
homolog), Grb2 (growth factor receptor-bound protein 2), SHP1 HCP (src homology region
inducible T-cell kinase), Lck (lymphocyte-speciﬁc protein tyrosine kinase), Nck (non-cataly
(Ras GTPase-activating protein), Src (v-src sarcoma viral oncogene homolog) and STAT3 (to promote growth cone collapse. Interestingly, ErbB2 and PLCγ are
not required for PlxnB1-mediated R-Ras inactivation (Swiercz et al.,
2009). Together, these results suggest that different tyrosine kinases
are involved in Plxn phosphorylation and that each kinase is likely to
modulate distinct Plxn-mediated events.
PlxnD1 interacts physically with tyrosine kinases
PlxnD1 forms a complex with VEGFR2 within a ternary complex
that also includes Nrp1. The PlxnD1/Nrp1/VEGFR2 complex promotes
Sema3E-induced/VEGFR2-mediated growth of subicular axons. While
this event does not appear to involve the phosphorylation of PlxnD1's
tyrosine residues (Bellon et al., 2010), it is possible that in other
contexts VEGFR2might phosphorylate PlxnD1 to modify its activity. It
would be interesting to determine if this is the case in the
endothelium, where all three proteins are expressed.
In addition, in human lung carcinoma cells p61Sema3E induces the
formation of a PlxnD1–ErbB2 complex in which both partners are
phosphotyrosinated. Remarkably, PlxnD1 phosphorylation requires
ErbB2's kinase activity. However, ErbB2's activation usually involves
its transphosphorylation in association with either EGFR (Epidermal
Growth Factor Receptor) or ErbB3. Accordingly, p61Sema3E also
induces EGFR tyrosine phosphorylation. Thus, it remains unclear if
ErbB2, EGFR or both mediate PlxnD1's tyrosine phosphorylation. In
addition, the speciﬁc tyrosine residue(s) of PlxnD1 phosphorylated in
carcinoma cells in response to p61Sema3E treatment have not been
reported (Casazza et al., 2010).
Plxns are also serine phosphorylated
Plxns are also phosphorylated at cytosolic Serine (S) residues, but
the role of this modiﬁcation remains to be characterized (see Phospho.
ELM server) and (Collins et al., 2005; Dai et al., 2007; Trost et al., 2009).
A candidate for this activity is the cAMP (cyclic adenosine monopho-
sphate)-dependent protein kinase A (PKA) which phosphorylates S
and Threonine (T) residues on its substrates and has been implicated
as a negative regulator of Sema1a/PlxnA-induced axonal repulsion
(see comments about Nervy on Box 3). The S/T phosphorylation of
PlxnD1 has not been reported. However, PlxnD1 proteins contain six
conserved predicted PKA phosphorylation sites (Table 2).ubfamilies), blue (PlxnD1-speciﬁc), black (shared with another Plxn subfamily) or grey
old (0.5) are in bold. Superscripts refer to the database used for predictions as follows:
o.org/), N (NetPhos 2.0; http://www.cbs.dtu.dk/services/NetPhos/), P (PhosphoMotif
du). Kinases: ABL (c-abl Abelson murine leukemia viral oncogene homolog 1), ALK
e kinase), EGFR (epidermal growth factor receptor), EPHA (Eph receptor A), FAK (focal
ardner-Rasheed feline sarcoma viral oncogene homolog), FMS (Friend murine leukemia
-oncogene tyrosine-protein kinase fyn), JAK (Janus Kinase or TYK2, tyrosine kinase 2),
GFR (platelet-derived growth factor receptor), RET (ret proto-oncogene), Src (v-src
and VEGFR (vascular endothelial growth factor receptor). Phosphatases: PTP1B (Ptpn1/
ontaining phosphatase 1 or HCP; hematopoietic cell phosphatase) and TC-PTP (PTPN2/
H2 (Src homology 2) or PTB (phosphotyrosine-binding) domains of ABL (c-abl Abelson
rk sarcoma virus CT10 oncogene homolog), Csk (c-src tyrosine kinase), FRIP (IL-Four
tyrosine-protein kinase fyn), FGR (Gardner-Rasheed feline sarcoma viral oncogene
2 domain-containing phosphatase 1 or HCP; hematopoietic cell phosphatase), Itk (IL2-
tic region of tyrosine kinase adaptor protein), PLCg (phospholipase C gamma), RasGAP
Signal transducer and activator of transcription 3).
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Thebiological rolesof Sema–PlxnD1signalingarebeingelucidated at
a fast pace. The recent isolation of the ﬁrst candidate modulator/
effectors of PlxnD1 promises to illuminate the molecular mechanisms
by which the Sema–PlxnD1 pathway orchestrates organ morphogen-
esis. Key future research directions in this exciting ﬁeld include
elucidation of the Sema/PlxnD1-speciﬁc functions of new cascade
components such as GIPC1, GTPases (both R-Ras and Rho-like),
cytoskeletal binding proteins and other Plxn effectors/modulators and
deﬁning if these molecules play similar or distinct roles in different
tissues, determine howNrp1 and VEGFR2, which are co-expressedwith
PlxnD1 in both the vascular and nervous systems, contribute to the
differential effects—repulsion vs attraction—of Sema–PlxnD1 signaling
in these tissues (Bellon et al., 2010; Chauvet et al., 2007; Christensen
et al., 2005), understand how PlxnD1 signals are integrated with the
inputs of other cascades to modulate the development of different
organs (see Alvarez et al., 2009; Childs et al., 2002; Choi et al., 2008;
Eickholt, 2008; Lamont et al., 2009; Moriya et al., 2010) and uncovering
the factors that regulate the expression patterns, levels, stability and
activity of Sema–PlxnD1 signaling components (for example, see Franco
and Tamagnone, 2008; Liu et al., 2005; Parra and Zou, 2010). Finally,
it is critical to explore the potential of Sema–PlxnD1 signaling as a
therapeutic target for improving the health of patients suffering from
ischemia, vascular disorders, cancer and nerve regeneration deﬁcits
(see Casazza et al., 2010; Galamb et al., 2008; Moriya et al., 2010;
Neufeld and Kessler, 2008; Pasterkamp and Giger, 2009; Roodink et al.,
2005; Rozanov et al., 2008; Suzuki et al., 2003).
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